SHENZHEN READLINE BIOTECH CO LTD

China

Overview

SHENZHEN READLINE BIOTECH CO LTD is an active pharmaceutical ingredient (API) supplier with 5 active FDA Type II Drug Master Files, covering NICOTINAMIDE ADENINE DINUCLEOTIDE; SEMAGLUTIDE; SEMAGLUTIDE MAIN CHAIN; SEMAGLUTIDE SIDE CHAIN; TIRZEPATIDE SIDE CHAIN.

API / Drug Master Files

SHENZHEN READLINE BIOTECH CO LTD holds 5 active (5 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • NICOTINAMIDE ADENINE DINUCLEOTIDEActive2025-11-07
  • SEMAGLUTIDE SIDE CHAINActive2025-05-19
  • TIRZEPATIDE SIDE CHAINActive2025-03-16
  • SEMAGLUTIDE MAIN CHAINActive2025-01-05
  • SEMAGLUTIDEActive2024-04-23

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHENZHEN READLINE BIOTECH CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.

Related companies

11 Battalion Medical Technology Co., Ltd
China
3D Medicines Inc.
China
3r Environmental Technology Co., Ltd
China
4u Health Co., Ltd
China
5 Plus (ningbo) Healthcare And Technology Co., Ltd.
China
A & D Electronics (shenzhen) Co., Ltd.
China
A-gen Biotech
China
A-one Medical Supplies
China

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo